MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma

References

• Chua MLK, Wee JTS, Hui EP, et al. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024.
   PubMed Web of Science ®Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704–714.
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Katsura A, Matsuyama H, et al. MicroRNA regulons in tumor microenvironment. Oncogene. 2015;34(24):3085–3094.
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257–2261.
   PubMed Web of Science ®Google Scholar
• Li H, Jin X, Chen B, et al. Autophagy-regulating microRNAs: potential targets for improving radiotherapy. J Cancer Res Clin Oncol. 2018;144(9):1623–1634.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Levine B, et al. Metabolic control of autophagy. Cell. 2014;159(6):1263–1276.
   PubMed Web of Science ®Google Scholar
• Doherty J, Baehrecke EH. Life, death and autophagy. Nat Cell Biol. 2018;20(10):1110–1117.
   PubMed Web of Science ®Google Scholar
• Zhan L, Li J, Wei B. Autophagy therapeutics: preclinical basis and initial clinical studies. Cancer Chemother Pharmacol. 2018;82(6):923–934.
   PubMed Web of Science ®Google Scholar
• Katheder NS, Khezri R, O’Farrell F, et al. Microenvironmental autophagy promotes tumour growth. Nature. 2017;541(7637):417–420.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–676.
   PubMed Web of Science ®Google Scholar
• Henry WS, Laszewski T, Tsang T, et al. Aspirin suppresses growth in PI3K-Mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling. Cancer Res. 2017;77(3):790–801.
   PubMed Web of Science ®Google Scholar
• Bae SY, Byun S, Bae SH, et al. TPT1 (tumor protein, translationally-controlled 1) negatively regulates autophagy through the BECN1 interactome and an MTORC1-mediated pathway. Autophagy. 2017;13(5):820–833.
   PubMed Web of Science ®Google Scholar
• Bishop E, Bradshaw TD. Autophagy modulation: a prudent approach in cancer treatment? Cancer Chemother Pharmacol. 2018;82(6):913–922.
   PubMed Web of Science ®Google Scholar
• Guo W, Wang H, Yang Y, et al. Down-regulated miR-23a contributes to the metastasis of cutaneous melanoma by promoting autophagy. Theranostics. 2017;7(8):2231–2249.
   PubMed Web of Science ®Google Scholar
• Huang L, Hu C, Cao H, et al. MicroRNA-29c increases the chemosensitivity of pancreatic cancer cells by inhibiting USP22 mediated autophagy. Cell Physiol Biochem. 2018;47(2):747–758.
   PubMedGoogle Scholar
• Hu JL, He GY, Lan XL, et al. Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer. Oncogenesis. 2018;7(2):16.
   PubMedGoogle Scholar
• Wu H, Liu C, Yang Q, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy. 2019;16(4):683–697.
   Web of Science ®Google Scholar
• Li X, Zhu Y, Zhang H, et al. MicroRNA-106a-5p inhibited c2c12 myogenesis via targeting PIK3R1 and modulating the PI3K/AKT signaling. Genes (Basel). 2018;9:7.
   Web of Science ®Google Scholar
• Yang G, Zhang R, Chen X, et al. MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl). 2011;89(10):1037–1050.
   PubMed Web of Science ®Google Scholar
• Xia X, Lu H, Li C, et al. miR-106b regulates the proliferation and differentiation of neural stem/progenitor cells through Tp53inp1-Tp53-Cdkn1a axis. Stem Cell Res Ther. 2019;10(1):282.
   PubMed Web of Science ®Google Scholar
• Lee SL, Rouhi P, Dahl Jensen L, et al. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A. 2009;106(46):19485–19490.
   PubMed Web of Science ®Google Scholar
• Shan Y, You B, Shi S, et al. Hypoxia-induced matrix metalloproteinase-13 expression in exosomes from nasopharyngeal carcinoma enhances metastases. Cell Death Dis. 2018;9(3):382.
   PubMedGoogle Scholar
• Gou WF, Yang XF, Shen DF, et al. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy. Oncotarget. 2015;6(23):19841–19867.
   PubMedGoogle Scholar
• Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000;103(2):253–262.
   PubMed Web of Science ®Google Scholar
• Tan G, Tang X, Tang F. The role of microRNAs in nasopharyngeal carcinoma. Tumour Biol. 2015;36(1):69–79.
   PubMedGoogle Scholar
• Luo B, Kang N, Chen Y, et al. Oncogene miR-106a promotes proliferation and metastasis of prostate cancer cells by directly targeting PTEN in vivo and in vitro. Minerva Med. 2018;109(1):24–30.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang B, Shi Y, et al. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. 2015;34(11):1407–1419.
   PubMed Web of Science ®Google Scholar
• Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133(2):217–222.
   PubMed Web of Science ®Google Scholar
• Chen C, Lu Z, Yang J, et al. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21. Cancer Med. 2016;5(12):3489–3499.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhou S, Luo H, et al. miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT. Int J Clin Exp Pathol. 2019;12(1):229–240.
   PubMed Web of Science ®Google Scholar
• Deng P, Wu Y. Knockdown of miR-106a suppresses migration and invasion and enhances radiosensitivity of hepatocellular carcinoma cells by upregulating FBXW7. Int J Clin Exp Pathol. 2019;12(4):1184–1193.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Wang H, et al. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFbetaR2. Int J Clin Exp Pathol. 2018;11(12):5622–5634.
   PubMed Web of Science ®Google Scholar
• Chao H, Zhang M, Hou H, et al. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p. Life Sci. 2020;243:117296.
   PubMed Web of Science ®Google Scholar
• Yang H, Ni HM, Ding WX. The double-edged sword of MTOR in autophagy deficiency induced-liver injury and tumorigenesis. Autophagy. 2019;15(9):1671–1673.
   Google Scholar
• Lin DC, Meng X, Hazawa M, et al. The genomic landscape of nasopharyngeal carcinoma. Nat Genet. 2014;46(8):866–871.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang MX, Zou X, et al. A prognostic bio-model based on SQSTM1 and N-stage identifies nasopharyngeal carcinoma patients at high risk of metastasis for additional induction chemotherapy. Clin Cancer Res. 2018;24(3):648–658.
   PubMed Web of Science ®Google Scholar
• Zhu JF, Huang W, Yi HM, et al. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation. Cell Death Dis. 2018;9(12):1154.
   PubMedGoogle Scholar
• Mo N, Lu YK, Xie WM, et al. Inhibition of autophagy enhances the radiosensitivity of nasopharyngeal carcinoma by reducing Rad51 expression. Oncol Rep. 2014;32(5):1905–1912.
   PubMed Web of Science ®Google Scholar
• Lin YT, Wang HC, Hsu YC, et al. Capsaicin induces autophagy and apoptosis in human nasopharyngeal carcinoma cells by downregulating the PI3K/AKT/mTOR Pathway. Int J Mol Sci. 2017;18:7.
   Web of Science ®Google Scholar
• Ai J, Li W, Zeng R, et al. Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro. Biomed Pharmacother. 2016;83:1022–1031.
   PubMed Web of Science ®Google Scholar
• Lin YT, Wang HC, Chuang HC, et al. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. J Mol Med (Berl). 2018;96(12):1407–1418.
   PubMed Web of Science ®Google Scholar
• Cheng JZ, Chen JJ, Wang ZG, et al. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-beta1/mTOR axis and HOXC6 in nasopharyngeal carcinoma. Cancer Biomark. 2018;23(1):107–123.
   PubMed Web of Science ®Google Scholar
• Hai B, Ma Y, Pan X, et al. Melatonin benefits to the growth of human annulus fibrosus cells through inhibiting miR-106a-5p/ATG7 signaling pathway. Clin Interv Aging. 2019;14:621–630.
   PubMed Web of Science ®Google Scholar
• Chen K, Pan G. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients. Pathol Res Pract. 2019;215(12):152686.
   PubMed Web of Science ®Google Scholar
• Hao H, Xia G, Wang C, et al. miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7. Med Mol Morphol. 2017;50(2):76–85.
   PubMed Web of Science ®Google Scholar
• Wang X, Blagden C, Fan J, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev. 2005;19(14):1715–1722.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen G, Cao X, et al. Downregulation of BTG3 in non-small cell lung cancer. Biochem Biophys Res Commun. 2013;437(1):173–178.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
   PubMed Web of Science ®Google Scholar
• Luo LH, Jin M, Wang LQ, et al. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. J Cell Physiol. 2020;235:6154–6166.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu X, Ni X, et al. Long non-coding RNA H19 modulates proliferation and apoptosis in osteoarthritis via regulating miR-106a-5p. J Biosci. 2019;44:6.
   PubMed Web of Science ®Google Scholar
• Wang LW, Li XB, Liu Z, et al. Long non-coding RNA OIP5-AS1 promotes proliferation of gastric cancer cells by targeting miR-641. Eur Rev Med Pharmacol Sci. 2019;23(24):10776–10784.
   PubMed Web of Science ®Google Scholar
• Cong J, Wang C, Pu D, et al. Expression of early growth response 1 affects miR-106a/signal transducer and activator of transcription 3 regulating cognitive impairment in ovariectomized mice. Menopause. 2014;21(10):1143–1150.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jiang YY, Xie JJ, et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018;9(1):3619.
   PubMedGoogle Scholar
• Bao L, You B, Shi S, et al. Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10. Oncogene. 2018;37(21):2873–2889.
   PubMed Web of Science ®Google Scholar
• You B, Shan Y, Shi S, et al. Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma. Cancer Sci. 2015;106(11):1506–1514.
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang YH, Huang FY, et al. 3ʹ-epi-12beta-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells. Theranostics. 2018;8(7):2044–2060.
   PubMed Web of Science ®Google Scholar